Ming Lim With Team Highlights The Importance of Identifying NSHA Patients
Ming Lim, Clinical Associate Professor at University of Utah, shared on LinkedIn:
“Using the My Life Our Future Research Repository, we analyzed the largest known cohort of individuals with non-severe hemophilia A (NSHA) who developed inhibitors (n=142). We identified 70 distinct F8 gene variants where inhibitor development occurred in a multiethnic cohort. These findings highlight the importance of identifying NSHA patients at-risk for inhibitors to improve clinical management and outcomes.
This study took years in the making, and would not have been possible without the support of the HTRS Mentored Research Award, Nigel Key, Jill Johnsen, Kristy Lee, American Thrombosis and Hemostasis Network (ATHN) and Tammuella Chrisentery-Singleton, and the My Life Our Future Research Repository.”
Title: F8 Variants and Inhibitor Development in a Multiethnic Cohort of Nonsevere Haemophilia A
Authors: Ming Y. Lim, Kristy Lee, Jill M. Johnsen, Nigel S. Key
Read full article here.
Stay updated about latest Haemophilia A news with Hemostasis Today.
-
Oct 24, 2026, 11:40Uli Schotten: Coagulation Factors May Influence Cardiac Remodelling
-
Oct 24, 2026, 11:20Edward Lee Carter: Anticoagulation After Intracranial Hemorrhage – Encouraging Data, but an Unresolved Tradeoff
-
Oct 24, 2026, 11:16Aram Hovhannisyan: New Evidence on CAT from the THEO Study
-
Oct 24, 2026, 10:49Shahram Kordasti: Investigating Novel Immune Targets in MPN
-
Oct 24, 2026, 10:32Amber Yates: A Major Milestone for the RISE UP Phase 3 Study
-
Oct 24, 2026, 10:22Emmanuel J Favaloro: Laboratory Diagnostics in Hemostasis – The Final 2026 Issue
-
Oct 24, 2026, 10:13Rana Al-Hrout: Vitamin B12 Deficiency – Neurological Symptoms Without Anemia
-
Oct 24, 2026, 09:56Celebrating 30 Years of Collaboration in Haemophilia Care – WFH
-
Oct 24, 2026, 09:30Isabelle Mahé: Preventing Recurrent VTE in Cancer – What Does APICAT Show?